Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression

被引：0
|
作者：
M Zhu
R Tang
S Doshi
K S Oliner
S Dubey
Y Jiang
R C Donehower
T Iveson
E Y Loh
Y Zhang
机构：
[1] Translational Sciences,
[2] Amgen Inc.,undefined
[3] Global Clinical Development,undefined
[4] Amgen Inc.,undefined
[5] Oncology,undefined
[6] Johns Hopkins Medical Center,undefined
[7] The Johns Hopkins University School of Medicine,undefined
[8] Medical Oncology,undefined
[9] University Hospital Southampton,undefined
来源：
British Journal of Cancer | 2015年 / 112卷
关键词：
rilotumumab; MET; exposure-response analysis; pharmacokinetics; gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 437
页数：8
相关论文
共 50 条
  • [41] The role of tumour microenvironment in gastric cancer angiogenesis
    Brzozowa, Marlena
    Michalski, Marek
    Harabin-Slowinska, Marzena
    Wojnicz, Romuald
    PRZEGLAD GASTROENTEROLOGICZNY, 2014, 9 (06): : 325 - 328
  • [42] MET Expression and Amplification in Patients with Localized Gastric Cancer
    Janjigian, Yelena Y.
    Tang, Laura H.
    Coit, Daniel G.
    Kelsen, David P.
    Francone, Todd D.
    Weiser, Martin R.
    Jhanwar, Suresh C.
    Shah, Manish A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (05) : 1021 - 1027
  • [43] The Significance of MET Expression and Strategies of Targeting MET Treatment in Advanced Gastric Cancer
    Liao, Haiyan
    Tian, Tiantian
    Sheng, Yuling
    Peng, Zhi
    Li, Zhongwu
    Wang, Jingyuan
    Li, Yanyan
    Zhang, Cheng
    Gao, Jing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] Exposure-response analysis of cabozantinib in patients with metastatic renal cell cancer treated in routine care
    Krens, S. D.
    van Erp, N. P.
    Groenland, S.
    Moes, D. J. A.
    Desar, I. M. E.
    Mulder, S. F.
    Van Der Hulle, T.
    Steeghs, N.
    Van Herpen, C. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S602 - S602
  • [45] Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
    Rodier, Thomas
    Puszkiel, Alicja
    Cardoso, Evelina
    Balakirouchenane, David
    Narjoz, Celine
    Arrondeau, Jennifer
    Fallet, Vincent
    Khoudour, Nihel
    Guidi, Monia
    Vidal, Michel
    Decleves, Xavier
    Csajka, Chantal
    Alexandre, Jerome
    Cadranel, Jacques
    Fabre, Elizabeth
    Wislez, Marie
    Goldwasser, Francois
    Blanchet, Benoit
    PHARMACEUTICS, 2022, 14 (09)
  • [46] N-nitrosodimethylamine:: Hazard characterization and exposure-response analysis
    Liteplo, RG
    Meek, ME
    JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS, 2001, 19 (01): : 281 - 304
  • [47] Justification of Noninferiority Margin: Methodology Considerations in an Exposure-Response Analysis
    Wang, Y.
    Harigaya, Y.
    Cavaille-Coll, M.
    Colangelo, P.
    Reynolds, K. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (04) : 404 - 410
  • [48] 2-Butoxyethanol: Hazard characterization and exposure-response analysis
    Hughes, K
    Meek, ME
    Walker, M
    Turner, L
    Moir, D
    JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS, 2001, 19 (01): : 77 - 104
  • [49] Exposure-Response Analysis of Lurbinectedin Alone or With Doxorubicin in Overall Survival in Small Cell Lung Cancer
    Fudio, S.
    Perez-Ramos, L.
    Wang, Q.
    Lopez-Vilarino, J. A.
    Kahatt, C.
    Zeaiter, A.
    Lubomirov, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1182 - S1183
  • [50] Lung cancer mortality among European rock/slag wool workers: exposure-response analysis
    Dario Consonni
    Paolo Boffetta
    Gilles Ferro
    Rodolfo Saracci
    Aage Andersen
    Jenny Chang-Claude
    John W. Cherrie
    Rainer Frentzel-Beyme
    Johnni Hansen
    Jørgen Olsen
    Nils Plato
    Peter Westerholm
    Cancer Causes & Control, 1998, 9 : 411 - 416
12345